217 related articles for article (PubMed ID: 28797648)
1. Overview of transcriptomic analysis of all human proteases, non-proteolytic homologs and inhibitors: Organ, tissue and ovarian cancer cell line expression profiling of the human protease degradome by the CLIP-CHIP™ DNA microarray.
Kappelhoff R; Puente XS; Wilson CH; Seth A; López-Otín C; Overall CM
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt B):2210-2219. PubMed ID: 28797648
[TBL] [Abstract][Full Text] [Related]
2. Hu/Mu ProtIn oligonucleotide microarray: dual-species array for profiling protease and protease inhibitor gene expression in tumors and their microenvironment.
Schwartz DR; Moin K; Yao B; Matrisian LM; Coussens LM; Bugge TH; Fingleton B; Acuff HB; Sinnamon M; Nassar H; Platts AE; Krawetz SA; Linebaugh BE; Sloane BF
Mol Cancer Res; 2007 May; 5(5):443-54. PubMed ID: 17510311
[TBL] [Abstract][Full Text] [Related]
3. Protease degradomics: mass spectrometry discovery of protease substrates and the CLIP-CHIP, a dedicated DNA microarray of all human proteases and inhibitors.
Overall CM; Tam EM; Kappelhoff R; Connor A; Ewart T; Morrison CJ; Puente X; López-Otín C; Seth A
Biol Chem; 2004 Jun; 385(6):493-504. PubMed ID: 15255181
[TBL] [Abstract][Full Text] [Related]
4. The CLIP-CHIP oligonucleotide microarray: dedicated array for analysis of all protease, nonproteolytic homolog, and inhibitor gene transcripts in human and mouse.
Kappelhoff R; Overall C
Curr Protoc Protein Sci; 2009 Apr; Chapter 21():21.19.1-21.19.16. PubMed ID: 19365791
[TBL] [Abstract][Full Text] [Related]
5. Analysis of the degradome with the CLIP-CHIP microarray.
Kappelhoff R; Auf dem Keller U; Overall CM
Methods Mol Biol; 2010; 622():175-93. PubMed ID: 20135282
[TBL] [Abstract][Full Text] [Related]
6. Protease proteomics: revealing protease in vivo functions using systems biology approaches.
Doucet A; Overall CM
Mol Aspects Med; 2008 Oct; 29(5):339-58. PubMed ID: 18571712
[TBL] [Abstract][Full Text] [Related]
7. Different Preference of Degradome in Invasion versus Angiogenesis.
Ghaffari-Tabrizi-Wizsy N; Cvitic S; Tam-Amersdorfer C; Bilban M; Majali-Martinez A; Schramke K; Desoye G; Hiden U
Cells Tissues Organs; 2014; 200(3-4):181-94. PubMed ID: 26068777
[TBL] [Abstract][Full Text] [Related]
8. Expression profile of the Schistosoma japonicum degradome reveals differential protease expression patterns and potential anti-schistosomal intervention targets.
Liu S; Cai P; Piao X; Hou N; Zhou X; Wu C; Wang H; Chen Q
PLoS Comput Biol; 2014 Oct; 10(10):e1003856. PubMed ID: 25275570
[TBL] [Abstract][Full Text] [Related]
9. Microarrays for protease detection in tissues and cells.
Moin K; Schwartz D; Mullins SR; Sloane BF
Methods Mol Biol; 2009; 539():49-57. PubMed ID: 19377971
[TBL] [Abstract][Full Text] [Related]
10. The CLIP-CHIP oligonucleotide microarray: dedicated array for analysis of all protease, nonproteolytic homolog, and inhibitor gene transcripts in human and mouse.
Kappelhoff R; Overall C
Curr Protoc Protein Sci; 2007 Aug; Chapter 21():21.19.1-21.19.16. PubMed ID: 18429319
[TBL] [Abstract][Full Text] [Related]
11. Expression analysis of all protease genes reveals cathepsin K to be overexpressed in glioblastoma.
Verbovšek U; Motaln H; Rotter A; Atai NA; Gruden K; Van Noorden CJ; Lah TT
PLoS One; 2014; 9(10):e111819. PubMed ID: 25356585
[TBL] [Abstract][Full Text] [Related]
12. [Gene expression profiling of human ovarian epithelial tumors by digo nucleotide microarray].
Konno R
Hum Cell; 2001 Dec; 14(4):261-6. PubMed ID: 11925926
[TBL] [Abstract][Full Text] [Related]
13. Proteases: Pivot Points in Functional Proteomics.
Verhamme IM; Leonard SE; Perkins RC
Methods Mol Biol; 2019; 1871():313-392. PubMed ID: 30276748
[TBL] [Abstract][Full Text] [Related]
14. A novel protease homolog differentially expressed in breast and ovarian cancer.
Anisowicz A; Sotiropoulou G; Stenman G; Mok SC; Sager R
Mol Med; 1996 Sep; 2(5):624-36. PubMed ID: 8898378
[TBL] [Abstract][Full Text] [Related]
15. A genomic analysis of rat proteases and protease inhibitors.
Puente XS; López-Otín C
Genome Res; 2004 Apr; 14(4):609-22. PubMed ID: 15060002
[TBL] [Abstract][Full Text] [Related]
16. Analysis of gene expression profiles associated with cisplatin resistance in human ovarian cancer cell lines and tissues using cDNA microarray.
Sakamoto M; Kondo A; Kawasaki K; Goto T; Sakamoto H; Miyake K; Koyamatsu Y; Akiya T; Iwabuchi H; Muroya T; Ochiai K; Tanaka T; Kikuchi Y; Tenjin Y
Hum Cell; 2001 Dec; 14(4):305-15. PubMed ID: 11925933
[TBL] [Abstract][Full Text] [Related]
17. The Degradome database: expanding roles of mammalian proteases in life and disease.
Pérez-Silva JG; Español Y; Velasco G; Quesada V
Nucleic Acids Res; 2016 Jan; 44(D1):D351-5. PubMed ID: 26553809
[TBL] [Abstract][Full Text] [Related]
18. Global Protease Activity Profiling Identifies HER2-Driven Proteolysis in Breast Cancer.
Salcedo EC; Winter MB; Khuri N; Knudsen GM; Sali A; Craik CS
ACS Chem Biol; 2021 Apr; 16(4):712-723. PubMed ID: 33765766
[TBL] [Abstract][Full Text] [Related]
19. Intramembrane proteases as drug targets.
Verhelst SHL
FEBS J; 2017 May; 284(10):1489-1502. PubMed ID: 27889944
[TBL] [Abstract][Full Text] [Related]
20. Circulating Peptidome and Tumor-Resident Proteolysis.
Fan J; Ning B; Lyon CJ; Hu TY
Enzymes; 2017; 42():1-25. PubMed ID: 29054266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
